Inflammatory Bowel Disease Treatment Market Size Predicted To Hit USD 34.5 Billion By 2031 At 5.1% CAGR, Says AMR

(MENAFN- EIN Presswire)

Inflammatory Bowel disease treatment market 2025

Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, drives the growth of the market

PORTLAND, OR, UNITED STATES, January 31, 2025 /EINPresswire / -- Allied Market Research has published a study report with the title Inflammatory Bowel Disease Treatment Market Size accounted for USD 21.0 billion in 2021, and it is estimated to surpass around USD 34.5 billion by 2031, registering a CAGR of 5.1% from 2022 to 2031.

Rise in the prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, an increase in the development of new drugs, and increased government support for the management of inflammatory bowel disease drive the growth of the global inflammatory bowel disease treatment market. Based on type, the Crohn's disease segment is likely to maintain its dominance through 2031. Region-wise, Asia-Pacific would exhibit the fastest CAGR during the forecast period.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

Get Sample PDF Report with Graphs and Figures Here:

Top Inflammatory Bowel Disease Treatment Companies

. AbbVie Inc.
. Bristol Myers Squibb
. Celltrion Healthcare
. Eli-Lilly
. Johnson & Johnson Services Inc.
. Merck & Co, Inc.
. Novartis AG
. Pfizer Inc.
. Takeda Pharmaceutical Company Ltd.
. UCB S.A.

Inflammatory Bowel Disease Treatment Market Segmentation

By Type

. Ulcerative Colitis
. Crohn's Disease

By Drug Class

. TNF inhibitors
. Corticosteroids
. Aminosalicylates
. JAK inhibitors
. Anti-integrin
. IL inhibitors
. Others

By Distribution Channel

. Hospital Pharmacy
. Drug Store and Retail Pharmacy
. Online Pharmacy

Based on region, North America accounted for the largest share in 2021, contributing to more than two-fifths of the global inflammatory bowel disease treatment market, and is likely to dominate the market during the forecasted timeframe. However, Asia-Pacific is expected to exhibit the fastest CAGR of 6.6% during the forecast period. The research also analyzes the regions including Europe and LAMEA.

Purchase the Report:

Key Benefits For Stakeholders

. This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the inflammatory bowel disease drugs market analysis from 2021 to 2031 to identify the prevailing inflammatory bowel disease drugs market opportunity.
. The market research is offered along with information related to key drivers, restraints, and opportunities.
. Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
. In-depth analysis of the inflammatory bowel disease drugs market segmentation assists to determine the prevailing market opportunities.
. Major countries in each region are mapped according to their revenue contribution to the global market.
. Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
. The report includes an analysis of the regional as well as global inflammatory bowel disease drugs market trends, key players, market segments, application areas, and market growth strategies.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

. Which are the driving factors responsible for the growth of market?
. Which are the roadblock factors of this market?
. What are the new opportunities, by which market will grow in coming years?
. What are the trends of this market?
. Which are main factors responsible for new product launch?
. How big is the global & regional market in terms of revenue, sales and production?
. How far will the market grow in forecast period in terms of revenue, sales and production?
. Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
. How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
. Which region has more opportunities?

By Region Outlook

. North America
(U.S., Canada, Mexico)
. Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
. Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
. LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
...

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of“Market Research Reports” and“Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Market Research
+ 1 800-792-5285
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

MENAFN31012025003118003196ID1109151548